Skip to content
10-K

Annual Report

STRONGBRIDGE BIOPHARMA plc

0001558370-21-002288

← back to feed
Filed
Mar 3, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 22, 2021 67.51M sh
Shares Diluted FY 2020 · Dec 31, 2020 57.98M sh
Shares Diluted FY 2020 · Dec 31, 2019 55.38M sh
Shares Diluted FY 2020 · Dec 31, 2018 49.72M sh
Capex FY 2020 · Dec 31, 2020 $10K
Capex FY 2020 · Dec 31, 2019 $74K
Capex FY 2020 · Dec 31, 2018 $326K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$38.13M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$44.78M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$84.58M
Long Term Debt FY 2020 · Dec 31, 2020 $17.11M
Cash And Equivalents FY 2020 · Dec 31, 2020 $87.52M
Cash And Equivalents FY 2020 · Dec 31, 2019 $57.03M
Stockholders Equity FY 2020 · Dec 31, 2020 $65.61M
Stockholders Equity FY 2020 · Dec 31, 2019 $72.19M
Stockholders Equity FY 2020 · Dec 31, 2018 $112.96M
Stockholders Equity FY 2020 · Dec 31, 2017 −$11.91M
Current Liabilities FY 2020 · Dec 31, 2020 $21.13M
Current Liabilities FY 2020 · Dec 31, 2019 $24.29M
Total Liabilities FY 2020 · Dec 31, 2020 $55.5M
Total Liabilities FY 2020 · Dec 31, 2019 $45.45M
Current Assets FY 2020 · Dec 31, 2020 $92.35M
Current Assets FY 2020 · Dec 31, 2019 $83.54M
Total Assets FY 2020 · Dec 31, 2020 $121.1M
Total Assets FY 2020 · Dec 31, 2019 $117.64M
Eps Diluted FY 2020 · Dec 31, 2020 −$0.18
Eps Diluted FY 2020 · Dec 31, 2020 −$0.78
Eps Diluted FY 2020 · Sep 30, 2020 −$0.18
Eps Diluted FY 2020 · Jun 30, 2020 −$0.32
Eps Diluted FY 2020 · Mar 31, 2020 −$0.24
Eps Diluted FY 2020 · Dec 31, 2019 −$1.10
Eps Diluted FY 2020 · Dec 31, 2018 $0.31
Eps Basic FY 2020 · Dec 31, 2020 −$0.18
Eps Basic FY 2020 · Dec 31, 2020 −$0.78
Eps Basic FY 2020 · Sep 30, 2020 −$0.06
Eps Basic FY 2020 · Jun 30, 2020 −$0.32
Eps Basic FY 2020 · Mar 31, 2020 −$0.23
Eps Basic FY 2020 · Dec 31, 2019 −$0.17
Eps Basic FY 2020 · Dec 31, 2019 −$0.91
Eps Basic FY 2020 · Sep 30, 2019 −$0.25
Eps Basic FY 2020 · Jun 30, 2019 −$0.15
Eps Basic FY 2020 · Mar 31, 2019 −$0.34
Eps Basic FY 2020 · Dec 31, 2018 $0.69
Sga Expense FY 2020 · Dec 31, 2020 $40.87M
Sga Expense FY 2020 · Dec 31, 2019 $49.06M
Sga Expense FY 2020 · Dec 31, 2018 $63.34M
Rd Expense FY 2020 · Dec 31, 2020 $25.8M
Rd Expense FY 2020 · Dec 31, 2019 $30.9M
Rd Expense FY 2020 · Dec 31, 2018 $25.44M
Net Income FY 2020 · Dec 31, 2020 −$11.95M
Net Income FY 2020 · Dec 31, 2020 −$45.08M
Net Income FY 2020 · Sep 30, 2020 −$3.16M
Net Income FY 2020 · Jun 30, 2020 −$17.27M
Net Income FY 2020 · Mar 31, 2020 −$12.7M
Net Income FY 2020 · Dec 31, 2019 −$8.98M
Net Income FY 2020 · Dec 31, 2019 −$49.45M
Net Income FY 2020 · Sep 30, 2019 −$13.79M
Net Income FY 2020 · Jun 30, 2019 −$8.25M
Net Income FY 2020 · Mar 31, 2019 −$18.43M
Net Income FY 2020 · Dec 31, 2018 $31.85M
Operating Income FY 2020 · Dec 31, 2020 −$43.17M
Operating Income FY 2020 · Dec 31, 2019 −$67.09M
Operating Income FY 2020 · Dec 31, 2018 −$81.92M
Revenue FY 2020 · Dec 31, 2020 $30.73M
Revenue FY 2020 · Dec 31, 2019 $21.71M
Revenue FY 2020 · Dec 31, 2018 $18.03M